ACET - NASDAQ
Adicet Bio, Inc.
$8.15
+4.1%Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
At a Glance
Live SnapshotAdicet Bio, Inc. Dividend History
ACET Dividend Payment History
Total Payments
32
Latest Dividend
$0.0100
Annual Amount
$0.1500
Frequency
Quarterly
| Declaration | Ex-Date | Payment Date | Dividend | Adjusted | Frequency | Growth |
|---|---|---|---|---|---|---|
Sep 6, 2018 | Sep 24, 2018 | Oct 9, 2018 | $0.0000 | $0.0100 | Quarterly | 0.00% |
May 3, 2018 | Jun 8, 2018 | Jun 22, 2018 | $0.0000 | $0.0100 | Quarterly | -84.62% |
Feb 1, 2018 | Mar 9, 2018 | Mar 23, 2018 | $0.0010 | $0.0650 | Quarterly | 0.00% |
Dec 7, 2017 | Dec 18, 2017 | Dec 28, 2017 | $0.0010 | $0.0650 | Quarterly | 0.00% |
Aug 24, 2017 | Sep 8, 2017 | Sep 21, 2017 | $0.0010 | $0.0650 | Quarterly | 0.00% |
May 5, 2017 | Jun 9, 2017 | Jun 23, 2017 | $0.0010 | $0.0650 | Quarterly | 0.00% |
Feb 3, 2017 | Mar 10, 2017 | Mar 24, 2017 | $0.0010 | $0.0650 | Quarterly | 0.00% |
Dec 2, 2016 | Dec 12, 2016 | Dec 22, 2016 | $0.0010 | $0.0650 | Quarterly | 0.00% |
Aug 26, 2016 | Sep 9, 2016 | Sep 20, 2016 | $0.0010 | $0.0650 | Quarterly | +8.33% |
May 6, 2016 | Jun 9, 2016 | Jun 24, 2016 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Feb 5, 2016 | Mar 11, 2016 | Mar 25, 2016 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Dec 4, 2015 | Dec 17, 2015 | Dec 28, 2015 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Sep 11, 2015 | Sep 21, 2015 | Oct 2, 2015 | $0.0000 | $0.0600 | Quarterly | 0.00% |
May 8, 2015 | Jun 11, 2015 | Jun 25, 2015 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Feb 6, 2015 | Mar 12, 2015 | Mar 26, 2015 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Dec 5, 2014 | Dec 15, 2014 | Dec 29, 2014 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Sep 5, 2014 | Sep 15, 2014 | Sep 29, 2014 | $0.0000 | $0.0600 | Quarterly | 0.00% |
May 9, 2014 | Jun 12, 2014 | Jun 27, 2014 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Feb 7, 2014 | Mar 13, 2014 | Mar 28, 2014 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Dec 6, 2013 | Dec 16, 2013 | Dec 27, 2013 | $0.0000 | $0.0600 | Quarterly | 0.00% |
Aug 29, 2013 | Sep 16, 2013 | Sep 27, 2013 | $0.0000 | $0.0600 | Quarterly | +9.09% |
May 10, 2013 | Jun 14, 2013 | Jun 25, 2013 | $0.0000 | $0.0550 | Quarterly | 0.00% |
Feb 8, 2013 | Mar 15, 2013 | Mar 26, 2013 | $0.0000 | $0.0550 | Quarterly | 0.00% |
Dec 7, 2012 | Dec 17, 2012 | Dec 28, 2012 | $0.0000 | $0.0550 | Quarterly | -8.33% |
Sep 10, 2012 | Sep 13, 2012 | Sep 28, 2012 | $0.0000 | $0.0600 | Quarterly | -40.00% |
May 7, 2012 | Jun 7, 2012 | Jun 22, 2012 | $0.0010 | $0.1000 | Semi-Annual | 0.00% |
Dec 9, 2011 | Dec 23, 2011 | Jan 18, 2012 | $0.0010 | $0.1000 | Semi-Annual | 0.00% |
May 9, 2011 | Jun 9, 2011 | Jun 24, 2011 | $0.0010 | $0.1000 | Semi-Annual | 0.00% |
Dec 6, 2010 | Dec 22, 2010 | Jan 21, 2011 | $0.0010 | $0.1000 | Semi-Annual | 0.00% |
May 10, 2010 | Jun 10, 2010 | Jun 25, 2010 | $0.0010 | $0.1000 | Semi-Annual | 0.00% |
Dec 11, 2009 | Dec 22, 2009 | Jan 15, 2010 | $0.0010 | $0.1000 | Quarterly | 0.00% |
May 11, 2009 | Jun 11, 2009 | Jun 26, 2009 | $0.0010 | $0.1000 | Quarterly | - |
Adicet Bio, Inc. Payout Ratio Analysis
Dividend Sustainability Analysis
Payout Ratio
Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.
FCF Payout Ratio
Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.
Sustainability
Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.
Related Guides
Continue your ACET research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.